ADvantage Therapeutics, Inc.
Amendment
CIK: 0001869338·Other Health Care·DELAWARE·Filed: Jul 28, 2025
Total Offering
$25,449,956
Amount Sold
$13,737,491
Investors
24
First Sale
Jun 28, 2023
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2021
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Frank Mattner | Related Person |
| David Buchsbaum | Related Person |
| Walter Schmidt | Related Person |
| Jeffrey B. Madden | Related Person |
| Agustin Fernandez Santana III | Related Person |
Company
SEC Filing
0001869338-25-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free